Daria Domanska
Lodz, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Journal: International journal of oncology
Published: April 04, 2016
Expression of HIF-1A/VEGF/ING-4 Axis in Pulmonary Sarcoidosis.
Journal: Advances in experimental medicine and biology
Published: May 30, 2015
Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer.
Journal: Advances in experimental medicine and biology
Published: March 11, 2015
TGF-β and SMADs mRNA Expression in Pulmonary Sarcoidosis.
Journal: Advances in experimental medicine and biology
Published: March 11, 2015
Single nucleotide polymorphisms in the STAT3 gene influence AITD susceptibility, thyroid autoantibody levels, and IL6 and IL17 secretion.
Journal: Cellular & molecular biology letters
Published: August 22, 2014
Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.
Journal: PloS one
Published: January 17, 2014
STAT3 rs3816769 polymorphism correlates with gene expression level and may predispose to nonsmall cell lung cancer: a preliminary study.
Journal: Polskie Archiwum Medycyny Wewnetrznej
Published: January 03, 2014
HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Journal: Medical oncology (Northwood, London, England)
Published: December 18, 2013
CTLA-4 polymorphisms (+49 A/G and -318 C/T) are important genetic determinants of AITD susceptibility and predisposition to high levels of thyroid autoantibodies in Polish children - preliminary study.
Journal: Acta biochimica Polonica
Published: August 28, 2013
Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.
Journal: BioMed research international
Published: April 23, 2013
Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.
Journal: Medical oncology (Northwood, London, England)
Published: January 15, 2013
Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.
Journal: Medical oncology (Northwood, London, England)
Published: October 21, 2012
Last Updated: 09/26/2026